InBioGen Co Ltd (101140) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.09x

InBioGen Co Ltd (101140) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting ₩117.75 Million (capex ₩60.00 Million plus investments ₩-57.75 Million) from operating cash flow of ₩1.36 Billion. See 101140 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.09x

(Capex + Investments) / Operating CF

Total Reinvested

₩117.75 Million

Capex + Investments

Operating Cash Flow

₩1.36 Billion

KRW

Capital Expenditures

₩60.00 Million

KRW

InBioGen Co Ltd Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for InBioGen Co Ltd across 1 annual periods. For the full cash flow conversion analysis, see InBioGen Co Ltd cash flow conversion.

Annual Cash Flow Reinvestment Rate for InBioGen Co Ltd (2016–2016)

Year-by-year capital reinvestment analysis for InBioGen Co Ltd. See InBioGen Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2016	0.03x	₩8.98 Million	₩344.75 Million	₩0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow